Skip to content
ClinChoice

Senior Scientist, Risk Management & Safety Surveillance

United States; United States United States
Senior · Safety
POSTED 29 OCT
Apply Ask
Role
17 days opentrue age
Posted 29 Oct
Pay
$102k–$170kno pay posted
Market p25–p75
$102k–$170k
United States · n=4366 · 365d to 15 Nov
CompanyClinChoice →
70open roles
Opened · 30d
+8
Closed · 30d
−8
10d of snapshots · 30d window
Market
29,026open · Senior Other
Opened · 7d
+2,95610% of open
All other
622,304open
All tracked boards · live 16 Nov · n=29,026
Visa
✓licensed sponsor
UK licensed sponsor
✓Worker (A rating)
Checked 15 Nov

ClinChoice is a global full-service CRO dedicated to professional development and providing an excellent work-life balance, with a quality-focused, collaborative “one-team” culture. We are looking for a dynamic person to join our in-house team as a Senior Scientist, Risk Management & Safety Surveillance on a permanent basis.

Responsibilities

Position Summary

The scientist will be responsible for core safety deliverables including scheduled and ad hoc aggregate reports and will serve as report owner for assigned reports (medium to large volume, standard complexity). He/She will have in- depth product knowledge and will support Safety Management Team (SMT) deliverables as required. Daily activities involve planning, conducting meetings, database searching, aggregate safety analysis and case level review, writing, and project management/coordination of strategic safety documents. He/She will partner with team members, stakeholders including Medical Safety Officers (MSOs), and a vendor.

Primary Responsibilities

• Ensure timely, quality reports/safety analyses related to core deliverables with oversight as appropriate

• Collaborate with Therapeutic Area Safety Head (TASH), MSO, Safety Surveillance Physician (SSP) and other stakeholders on strategy development

• Initiate, conduct, and oversee searches of internal and external databases

• Perform and/or lead aggregate safety analysis and case level review

• Author, contribute, and coordinate the preparation of core safety deliverables

• Ensure commitments (e.g., Pharmacovigilance Agreements (PVAs) and assessment reports) are met

• Partner with vendor to develop reports/deliverables

• Provide SMT support as needed

• Act as ad hoc member for assigned products as appropriate

• Recognize potential issues and or safety issues and escalate to the attention of the report owner, line manager, or MSO

• Ability to understand nature of adverse drug reactions and complex associations

• Maintains a high level of flexibility and ability to reprioritize ones work and others

• Attention to detail and ability to analyze data in broader context

• Ability to work across multiple functions and therapeutic areas

• Review regulatory assessor comments/requests and accommodate/address as appropriate with guidance

Training/Meetings/Department Initiatives:

• Participate in cross-functional training of relevant stakeholders

• Attend departmental meetings and trainings

• Participate in department and/or cross-functional initiatives

Secondary Responsibilities

• Safety Management Teams (SMT) for assigned products - Lead SMT meeting. Lead and drive discussions and formulate decisions along with core members

• Risk management plans - Provide guidance on RMP creation and updates. Reviews and align approvals with oversight leads of the Risk Management plan

• Periodic Benefit Risk Evaluation Report (PBRER)/ Periodic Safety Update Report (PSUR) - Reviews and align approvals with lead oversight. Leads strategy of the PBRER process.

• Health authority queries -Work with MSO, scientist to organize data, review cases, literature, write Marketing Authorization Holder (MAH) comments

• Participating Affiliate Core Data Sheets (CCDS), US and EU prescribing information updates - Form part of the label working group and provide guidance related to the label updates.

• Signal Validation and Evaluations - Work with Scientist to review preliminary data to determine if the signal is valid and would require further evaluation. Lead and drive the signal evaluation process

• IB updates for safety sections - Evaluate clinical data for ADRs, assist with section 5 and Reference Standard Information (RSI) tables as needed

• DSURs - Reviews and aligns Safety approvals with lead oversight.

• Addendum to Clinical Overviews - Provide support with review, and characterization of risks, data review

• Literature reviews for class effects and ad hoc reports -Review articles and create MAH Comments for assessment of the articles

• Product Safety Strategy (PSS) - Review the risks documented in the PSS and oversee the updates as necessary. Align approval of the PSS updates with oversight.

Source · ClinChoiceFirst seen 4 NovOriginal ↗